Ishihara, H., Takagi, T., Kondo, T., Tachibana, H., Yoshida, K., Omae, K., … Tanabe, K. (2018). Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-018-1241-3 (Original work published 2018)